SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-20-009230
Filing Date
2020-06-11
Accepted
2020-06-11 08:22:27
Documents
1
Period of Report
2020-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159187812734850.html 4  
1 FORM 4 wf-form4_159187812734850.xml 4 4179
  Complete submission text file 0001628280-20-009230.txt   5709
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O FIVE CORNERS CAPITAL 700 WEST GEORGIA STREET, SUITE 2500 VANCOUVER A1 V7Y 1B3
Business Address
Bridger Gary (Reporting) CIK: 0001600049 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38295 | Film No.: 20956230